Over the latest trailing 12-month period, price cagr is -84.84%. The comparable SPY value is +15.70%. Year-to-date price return is -83.47%. Price CAGR uses adjusted close price history and excludes dividends.
Over the past 12 months, Price CAGR is -84.84%. The price CAGR (Compound Annual Growth Rate) shows how the company's stock price has grown over various time periods. This measures pure price appreciation without including dividends.
Anbio Biotechnology Class A Ordinary Shares (NNNN)
Price growth vs the same calendar quarter one year earlier, last 4 comparable quarters.
Quarter-end adjusted closing prices; the newest quarter may be quarter-to-date. Q4 2026 (2026-10-05): $4.83.
| Year | Start Price | End Price | Change | % Change |
|---|---|---|---|---|
| 2026 (YTD) | $30.07 | $4.83 | −$25.24 | -83.94% |
| Period | Period End | Value | QoQ Return | YoY Return |
|---|---|---|---|---|
| Q4 2026 (QTD) | 2026-10-05 | $4.83 | -23.3% | -83.9% |
| Q3 2026 | 2026-09-30 | $6.30 | -54.0% | -83.1% |
| Q2 2026 | 2026-06-30 | $13.71 | -46.6% | -56.7% |
| Q1 2026 | 2026-03-31 | $25.69 | -14.6% | +244.4% |
| Q4 2025 | 2025-12-31 | $30.07 | -19.3% | N/A |
| Q3 2025 | 2025-09-30 | $37.25 | +17.7% | N/A |
| Q2 2025 | 2025-06-30 | $31.66 | +324.4% | N/A |
| Q1 2025 | 2025-03-31 | $7.46 | N/A | N/A |
Calendar returns: QoQ compares the prior calendar quarter; YoY compares the same calendar quarter a year earlier. The newest quarter is in progress (quarter-to-date).
